GentiBio

Last updated: May 09, 2024

Adel Nada, co-founder and CEO
Adel Nada, co-founder and CEO
Country: USA | Funding: $177M (+)

Website: http://www.gentibio.com/

GentiBio is a biotherapeutics company developing engineered regulatory T cells (EngTregs) programmed to treat autoimmune allergic diseases.